ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1690

Henoch-Schönlein Purpura Nephritis: Different Histological Classifications, but Which One Is Most Strongly Associated to the Outcome of the Disease? Pilot Study of the Paediatric Rheumatology European Society Vasculitis Working Party

Martina Held1, Mario Sestan1, Marijana Coric1, Stela Bulimbasic1, Teresa Giani2, Neil Martin3, Nastasia Cekada1, Sasa Srsen4, Ana Gudelj Gracanin5, Domagoj Kifer6, Merav Heshin7, Angelo Ravelli8, Rolando Cimaz9, Seza Ozen10, Alenka Gagro11, Marijan Frkovic1 and Marija Jelusic1, 1University of Zagreb School of Medicine, University Hospital Centre Zagreb, Zagreb, Croatia, Zagreb, Grad Zagreb, Croatia, 2Anna Meyer Children’s Hospital, Florence, Italy, Florence, Toscana, Italy, 3Royal Hospital for Children, Glasgow, United Kingdom, Glasgow, Scotland, United Kingdom, 4University Hospital Centre Split, University of Split School of Medicine, Split, Croatia, Split, Splitsko-Dalmatinska, Croatia, 5University Hospital Dubrava, University of Zagreb School of Medicine, Zagreb, Croatia, Zagreb, Grad Zagreb, Croatia, 6Faculty of Pharmacy and Biochemistry, Zagreb, Croatia, Zagreb, Grad Zagreb, Croatia, 7Dana Dwek Children's Hospital, Tel Aviv, Israel, Tel Aviv, Tel Aviv, Israel, 8Università degli Studi di Genova, Genoa, Italy, 9ASST Gaetano Pini-CTO Institute and Università degli Studi di Milano, Milan, Italy, Milan, Italy, 10Department of Pediatric Rheumatology, Hacettepe University, Ankara, Turkey, Ankara, Turkey, 11Children's Hospital Zagreb, Josip Juraj Strossmayer University of Osijek, Medical Faculty Osijek, Zagreb, Croatia, Zagreb, Grad Zagreb, Croatia

Meeting: ACR Convergence 2020

Keywords: Pediatric rheumatology, Vasculitis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 9, 2020

Title: Pediatric Rheumatology – Clinical Poster III: SLE, Vasculitis, & JDM

Session Type: Poster Session D

Session Time: 9:00AM-11:00AM

Background/Purpose: Henoch-Schönlein purpura nephritis (HSPN) is the main and almost the only cause of morbidity and mortality among children suffering from this most common vasculitis in childhood. Several classifications are used in the analysis of renal biopsies in HSPN, but it is unknown which one has the strongest association with the severity and outcome. The aim of the study was to compare the four most commonly used histological classifications for HSPN to determinate which one is the best predictor of disease outcome and to establish which variables of each histological classification have the strongest association with unfavorable outcomes.

Methods: The cross-sectional study included 69 patients with HSPN (diagnosed by EULAR/PRES/PRINTO criteria) and available renal biopsy specimens for analysis using 4 histological classifications for HSPN (the International Study of Kidney Disease in Children (ISKDC) classification, the Oxford classification, the Haas histologic classification of IgA nephropathy and the modified semi-quantitative classification (SQC), developed by Koskela et al.). The clinical outcome was defined through 4 categories, graded according to the modified classification of Counahan (physical examination, hematuria, proteinuria, urine albumin-to-creatinine ratio, hypertension and eGFR). The linear relationships between outcome and histological classifications were analysed using ordinal regressions using the first-order of polynomial orthogonal contrasts.

Results: The SQC classification proved to be the best, reducing the deviation (of the model-predicted outcome value from the observed value) by 9.5% (Χ21=13,89, p < 0,001), followed by the Oxford classification with a deviation reduction of 8.0% (Χ21=11,76, p = 0,001), then the ISKDC classification with a decrease in deviation of 3.3% (Χ21=4,89, p = 0,027), and the worst was the Haas classification with a decrease in deviation of 2.1% (Χ21=3,06, p = 0,080). Analysis of individual variables of Oxford and SQC classifications showed that with increasing values in the variables of interstitial fibrosis (t66 = 3,23, p = 0,002), tubular atrophy (t66 = 2,94, p = 0,005) and tubular dilatation (t66 = 2,40, p = 0,019) in the SQC classification, and endocapillary hypercellularity (t66 = 3,14, p = 0,003) and crescents (t66 = 2,07, p = 0,043) in the Oxford classification the outcome worsens.

Conclusion: The pilot study showed that the SQC classification, developed by Koskela et al., has the strongest association with the severity and outcome of HSPN, followed by the Oxford classification, while other classifications are less related to the outcome of the disease. Although crescents on renal biopsy were considered the most important outcome indicators, this pilot study suggests that tubulointerstitial changes could be even more important as predictors of poor outcome. Histological changes in the interstitium and renal tubules of HSPN patients should be further explored in order to have an even better predictive value in terms of disease outcomes and to be incorporated into existing or new classifications, on the basis of which guidelines for the treatment of patients would be developed.

SUPPORT: Croatian Science Foundation project IP-2019-04-8822.


Disclosure: M. Held, None; M. Sestan, None; M. Coric, None; S. Bulimbasic, None; T. Giani, None; N. Martin, None; N. Cekada, None; S. Srsen, None; A. Gudelj Gracanin, None; D. Kifer, None; M. Heshin, None; A. Ravelli, AbbVie, BMS, Pfizer, Hoffman LaRoche, Novartis, Centocor, "Francesco Angelini" and Reckitt Benckiser., 1, 2; R. Cimaz, None; S. Ozen, SOBI, 1, Novartis, 1; A. Gagro, None; M. Frkovic, None; M. Jelusic, None.

To cite this abstract in AMA style:

Held M, Sestan M, Coric M, Bulimbasic S, Giani T, Martin N, Cekada N, Srsen S, Gudelj Gracanin A, Kifer D, Heshin M, Ravelli A, Cimaz R, Ozen S, Gagro A, Frkovic M, Jelusic M. Henoch-Schönlein Purpura Nephritis: Different Histological Classifications, but Which One Is Most Strongly Associated to the Outcome of the Disease? Pilot Study of the Paediatric Rheumatology European Society Vasculitis Working Party [abstract]. Arthritis Rheumatol. 2020; 72 (suppl 10). https://acrabstracts.org/abstract/henoch-schonlein-purpura-nephritis-different-histological-classifications-but-which-one-is-most-strongly-associated-to-the-outcome-of-the-disease-pilot-study-of-the-paediatric-rheumatology-european/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2020

ACR Meeting Abstracts - https://acrabstracts.org/abstract/henoch-schonlein-purpura-nephritis-different-histological-classifications-but-which-one-is-most-strongly-associated-to-the-outcome-of-the-disease-pilot-study-of-the-paediatric-rheumatology-european/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology